UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNAI
5651
Lunai Bioworks
LNAI
$10.9M
| $638K | ﹤0.01% |
9,546
+8,965
| +1,543% | +$595K |
|
5652
Lands' End
LE
$403M
| $638K | ﹤0.01% |
48,586
+35,237
| +264% | +$553K |
|
|
NVRO
5653
DELISTED
NEVRO CORP.
NVRO
| $638K | ﹤0.01% |
171,417
+161,836
| +1,689% | +$747K |
|
5654
Tejon Ranch
TRC
$451M
| $638K | ﹤0.01% |
40,096
+20,533
| +105% | +$331K |
|
5655
Greenlight Captial
GLRE
$506M
| $637K | ﹤0.01% |
45,517
+32,434
| +248% | +$460K |
|
5656
Prime Medicine
PRME
$559M
| $637K | ﹤0.01% |
218,186
+183,165
| +523% | +$643K |
|
5657
Motorcar Parts of America
MPAA
$258M
| $637K | ﹤0.01% |
83,826
+82,918
| +9,132% | +$563K |
|
5658
Southern First Bancshares
SFST
$600M
| $637K | ﹤0.01% |
16,018
+10,558
| +193% | +$423K |
|
5659
INmune Bio
INMB
$57.7M
| $636K | ﹤0.01% |
136,248
+93,092
| +216% | +$485K |
|
5660
i3 Verticals
IIIV
$342M
| $635K | ﹤0.01% |
27,566
+8,327
| +43% | +$195K |
|
5661
Invesco S&P 500 Downside Hedged ETF
PHDG
$65M
| $634K | ﹤0.01% |
17,022
-626
| -4% | -$24K |
|
|
NEE.PRR
5662
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| $632K | ﹤0.01% |
15,447
-572
| -4% | -$25.1K |
|
5663
Caribou Biosciences
CRBU
$164M
| $630K | ﹤0.01% |
396,367
+239,049
| +152% | +$481K |
|
5664
iShares U.S. Carbon Transition Readiness Aware Active ETF
LCTU
$1.26B
| $629K | ﹤0.01% |
9,828
-1,288
| -12% | -$82.9K |
|
|
MVF
5665
DELISTED
BlackRock MuniVest Fund
MVF
| $629K | ﹤0.01% |
89,374
+11,935
| +15% | +$87.7K |
|
5666
PUT
Kimberly-Clark
KMB
$36.5B
| $629K | ﹤0.01% |
4,800
| – | – |
|
5667
Quantum Corp
QMCO
$474M
| $629K | ﹤0.01% |
11,665
+10,976
| +1,593% | +$159K |
|
5668
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$4.24B
| $628K | ﹤0.01% |
11,533
+8,855
| +331% | +$455K |
|
5669
CALL
Lantheus
LNTH
$6.59B
| $626K | ﹤0.01% |
7,000
| – | – |
|
|
5670
PUT
Lantheus
LNTH
$6.59B
| $626K | ﹤0.01% |
7,000
| – | – |
|
5671
Columbia Emerging Markets Consumer ETF
ECON
$306M
| $626K | ﹤0.01% |
30,172
+686
| +2% | +$14.9K |
|
|
CWBC
5672
Community West Bancshares
CWBC
$684M
| $625K | ﹤0.01% |
32,279
+22,564
| +232% | +$449K |
|
5673
KraneShares Global Carbon Strategy ETF
KRBN
$133M
| $622K | ﹤0.01% |
21,236
+17,755
| +510% | +$548K |
|
|
MCR
5674
DELISTED
MFS Charter Income Trust
MCR
| $622K | ﹤0.01% |
97,539
-17,327
| -15% | -$110K |
|
5675
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.03B
| $621K | ﹤0.01% |
11,461
+2,055
| +22% | +$118K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.